Consecutive intra-umbilical vein injection of misoprostol and intravenous sulprostone in the management of retained placenta

Archives of Gynecology and Obstetrics

Volumn 289, Issue 1, 2014, Pages 35-40

  Notten, Frouke ^a   Meertens, Linda ^b   Wissink, Brechtje ^b   Scheepers, Hubertina C J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Manual removal of placenta; Misoprostol; Postpartum haemorrhage; Retained placenta; Sulprostone

Indexed keywords

MISOPROSTOL; SULPROSTONE; OXYTOCIC AGENT; PROSTAGLANDIN E2;

ARTICLE; BLEEDING; CLINICAL PROTOCOL; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GESTATIONAL AGE; HUMAN; INTRA UMBILICAL VEIN INJECTION; LABOR STAGE 3; PLACENTAL DELIVERY; RETAINED PLACENTA; UMBILICAL VEIN; VAGINAL DELIVERY; ADULT; ANALOGS AND DERIVATIVES; INTRAVENOUS DRUG ADMINISTRATION; PLACENTA, RETAINED; PREGNANCY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVENOUS; ADULT; DINOPROSTONE; FEMALE; HUMANS; MISOPROSTOL; OXYTOCICS; PLACENTA, RETAINED; PREGNANCY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UMBILICAL VEINS;

EID: 84891874795     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-2919-4     Document Type: Article

References (11)

1. Carroli G, Bergel E (2001) Umbilical vein injection for management of retained placenta. Cochrane Database Syst Rev 4:CD001337
2. Van Beekhuizen HJ, de Groot AN, De Boo T, Burger D, Jansen N, Lotgering FK (2006) Sulprostone reduces the need for the manual removal of the placenta in patients with retained placenta: a randomized controlled trial. Am J Obstet Gynecol 194(2):446-450 (Pubitemid 43183699)
3. Bais JM, Eskes M, Pel M, Bonsel GJ, Bleker OP (2004) Postpartum haemorrhage in nulliparous women: incidence and risk factors in low and high risk women. A Dutch population-based cohort study on standard (≥500 ml) and severe (≥1,000 ml) post-partum haemorrhage. Eur J Obstet Gynecol Reprod Biol 115(2):166-172 (Pubitemid 38953034)
4. Weeks Andrew D (2008) The retained placenta. Best Pract Res Clin Obstet Gynaecol 22(6):1103-1117
5. Rogers MS, Yeun PM, Wong S (2007) Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using Pipingas technique for management of adherent placenta. Acta Obstet Gynecol Scand 86(1):48-54 (Pubitemid 46009526)
6. World Health Organization (2009) WHO guidelines for the management of postpartum haemorrhage and retained placenta. ISBN 978 92 4 159851 4
7. Hagenaars M, Knape JT, Backus EM (2011) Pulmonary oedema after high infusion rate of sulprostone. URL: http://bja.oxfordjournals.org. Accessed on 25 Apr 2011
8. Chen FG, Koh KF, Chong YS (1998) Cardiac arrest associated with sulprostone use during caesarean section. Anaesth Intensive Care 26(3):298-301 (Pubitemid 28251923)
9. Stefanovic V, Paavonen J, Loukovaara M, Halmesmäki E, Ahonen J, Tikkanen M (2013) Intravenous sulprostone infusion in the treatment of retained placenta. Acta Obstet Gynecol Scand 92(4):426-432
10. Nardin JM, Weeks A, Carroli G (2011) Umbilical vein injection for management of retained placenta. Cochrane Database Syst Rev Issue 5, CD001337. doi: 10.1002/14651858.CD001337
11. Harara R, Hanafy S, Saad Alsayed Zidan M, Alberry M (2011) Intraumbilical injection of three different uterotonics in the management of retained placenta. J Obst Gynaecol Res 37(9):1203-1207